主要成就
1.Polyamines disrupt the KaiABC oscillator by inducing protein denaturation. Jinkui Li#, Lingya Zhang, Junwen Xiong, Xiyao Cheng, Yongqi Huang, Zhengding Su, Ming Yi*, Sen Liu*. Molecules, 2019, 24(18): 3351.
2.Intrinsically Disordered Transactivation Domains Bind to TAZ1 Domain of CBP via Diverse Mechanisms. Meng Gao#, Jing Yang, Sen Liu, Zhengding Su, Yongqi Huang*. Biophysical Journal, 2019, 117(7): 1301-1310.
3.Structure-based reconstruction of a Mycobacterium hypothetical protein into an active Δ5–3-ketosteroid isomerase. Fei Peng#, Xiyao Cheng, Hongwei Wang, Shikui Song, Tian Chen, Xin Li, Yijun He, Yongqi Huang, Sen Liu, Fei Yang*, Zhengding Su*. BBA – Proteins and Proteomics, 2019, 1867(9): 821-830.
4.Recombinant butelase-mediated cyclization of the p53-binding domain of the oncoprotein MdmX stabilized protein conformation as a promising model for structural investigation. Ni Pi#, Meng Gao, Xiyao Cheng, Huili Liu, Zhengkun Kuang, Zixin Yang, Jing Yang, Bailing Zhang, Yao Chen, Sen Liu, Yongqi Huang, Zhengding Su*. Biochemistry, 2019, 58(27): 3005-3015.
5.The influence of intrinsic folding mechanism of an unfolded protein on the coupled folding-binding process during target recognition. Junwen Xiong#, Meng Gao, Jingjing Zhou, Sen Liu, Zhengding Su*, Zhirong Liu, Yongqi Huang*. Proteins: Structure, Function, Bioinformatics, 2019, 87(4): 265-275.
6.The reversible function switching of the circadian clock protein KaiA is encoded in its structural flexibility via 3-D domain swapping. Qiang Chen#, Sen Liu*, Liting Yang, Lingya Zhang, Jinkui Li. BBA-General Subjects, 2017, 1861(11): 2535-2542. (IF=4.722)
7.3D-quantitative structure–activity relationship and docking studies of coumarin derivatives as tissue kallikrein 7 inhibitors. Xin Zheng#, Mengxi He#, Xiao Tan*, Jun Zheng, Fangyu Wang, Sen Liu*. Journal of Pharmacy and Pharmacology, 2017, 69(9): 1136-1144. (IF=2.405)
8.Discovery of covalent ligands via noncovalent docking by dissecting covalent docking based on a “steric-clashes alleviating receptor (SCAR)” strategy. Yuanbao Ai#, Lingling Yu#, Xiao Tan#, Xiaoying Chai, Sen Liu*. Journal of Chemical Information and Modeling, 2016, 56(8): 1563-1575. (IF=3.738)
*** 封面论文
9.A dynamic interaction process between KaiA and KaiC is critical to the cyanobacterial circadian oscillator. Pei Dong#, Ying Fan, Jianqiang Sun, Mengting Lv, Ming Yi, Xiao Tan, Sen Liu*. Scientific Reports, 2016, 6: 25129. (IF=5.578)
10.Discovery of Novel Inhibitors of Human S-Adenosylmethionine Decarboxylase Based on in silico High-throughput screening and a Non-radioactive Enzymatic Assay. Chenzeng Liao#, Yanlin Wang, Xiao Tan, Lidan Sun, Sen Liu*. Scientific Reports, 2015, 5: 10754. (IF = 5.578)
11.Reliable cell cycle commitment in budding yeast is ensured by signal integration. Xili Liu#, Xin Wang#, Xiaojing Yang, Sen Liu, Lingli Jiang, Yimiao Qu, Lufeng Hu, Qi Ouyang, Chao Tang*. eLife 2015, 4: e03977. (IF = 9.322)
12.The P2/P2' Sites Affect the Substrate Cleavage of TNF-alpha Converting Enzyme (TACE). Sen Liu#*, Song Liu, Yanlin Wang, Zhaojiang Liao. Molecular Immunology, 2014, 62(1): 122-128. (IF = 2.973)
13.Control of Protein Signaling Using a Computationally Designed GTPase/GEF Orthogonal Pair. Gregory T. Kapp#, Sen Liu#, Derek T. Wong, Attila Reményi, Brian Yeh, Jack Taunton, Wendell A. Lim, and Tanja Kortemme*. Proc. Natl. Acad Sci USA, 2012, 109(14): 5277-5282. (IF = 9.674)
*** 封面推荐.
*** 专评: PNAS April 3, 2012 vol. 109 no. 14: 5140-5141.
14.Nonnatural protein–protein interaction-pair design by key residues grafting. Sen Liu#, Shiyong Liu#, Xiaolei Zhu, Huanhuan Liang, Aoneng Cao, Zhijie Chang, Luhua Lai*. Proc. Natl. Acad Sci USA 2007, 104(13): 5330-5335. (IF = 9.674)
15.免疫学实验进展. 刘森,“免疫信息学”。 章晓联主编,中华医学会中华医学电子音像出版社,《中国医学研究发展系列报告》丛书,2018年6月,ISBN:978-7-83005-171-6.
16.分子印记技术. 刘朝奇、王艳林、刘森主编. 化学工业出版社, 2012年2月, ISBN 978-7-122-11645-1.
17.PCR聚合酶链反应. 刘森主编. 化学工业出版社, 2009年1月, ISBN 978-7-122-03138-9.
18.ZL 200510086708.4,具有促红细胞生长因子活性 蛋白质及其用途,2008.11.12。发明人:来鲁华,曹傲能,刘森,刘士勇,常智杰,王银银,程龙。
19.ZL 201410530672.3,一种S-腺苷甲硫氨酸脱羧酶的活性检测方法及其应用,2015.12.30。发明人:刘森,廖陈曾,王艳林,占景琼。
20.ZL 201410134532.4,肿瘤坏死因子-α转化酶的多肽抑制剂的筛选方法及其应用,2016.03.16。发明人:刘森,刘朝奇,刘松,张伟。
21.ZL 201410534410.4,一种小分子抑制剂及在抑制S-腺苷甲硫氨酸脱羧酶上的应用,2017.01.11。发明人:刘森,廖陈曾,王艳林。
22.ZL 201410532418.7,小分子抑制剂及在抑制S-腺苷甲硫氨酸脱羧酶上的应用,2016.06.01。发明人:刘森,廖陈曾,王艳林。
23.ZL 201410530674.2,一种S-腺苷甲硫氨酸脱羧酶的药物口袋及其应用,2016.06.01。发明人:刘森,廖陈曾。
24.ZL 201410534409.1,一种小分子抑制剂及在抑制S-腺苷甲硫氨酸脱羧酶(AdoMetDC)上的应用,2016.07.06。发明人:刘森,廖陈曾,王艳林。
25.ZL 201510057907.6,一种小分子抑制剂及其在抑制S-腺苷甲硫氨酸脱羧酶上的应用,2016.09.07。发明人:刘森,廖陈曾,王艳林。
26.ZL 201410524151.7,一种小分子抑制剂及在抑制鸟氨酸脱羧酶上的应用,2017.02.15。发明人:刘森,王艳林,占景琼
27.ZL 201410525202.8,一种小分子抑制剂及在抑制鸟氨酸脱羧酶(ODC)上的应用,2017.06.06。发明人:刘森,王艳林,占景琼
28.ZL 201410524065.6,一种小分子抑制剂及其应用,2017.03.29。发明人:王艳林,刘森,占景琼